Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer’s Disease
Authors:
- D. Louis CollinsDCD. Louis Collins
- Pedro Rosa-NetoPRPedro Rosa-Neto
- John C.S. BreitnerJBJohn C.S. Breitner
- for the PREVENT-AD Research GroupFGfor the PREVENT-AD Research Group
Open Access
- 7 November 2017
- journal article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 60 (4) , 1589-1600
Abstract
Prevention of dementia due to Alzheimer’s disease (d/AD) requires interventions that slow the disease process prior to symptom onset. To develop such interventions, one needs metrics that assess pre-symptomatic disease progression. Familiar measuresKeywords
This publication has 84 references indexed in Scilit:
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's DiseaseNew England Journal of Medicine, 2012
- MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adultsNeurology, 2012
- Impairments of auditory scene analysis in Alzheimer's diseaseBrain, 2011
- Central Auditory Dysfunction as a Harbinger of Alzheimer DementiaJAMA Otolaryngology–Head & Neck Surgery, 2011
- Hearing Loss Prevalence and Risk Factors Among Older Adults in the United StatesThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2011
- Executive Dysfunction and Presbycusis in Older Persons With and Without Memory Loss and DementiaCognitive and Behavioral Neurology, 2010
- Structural MRI biomarkers for preclinical and mild Alzheimer's diseaseHuman Brain Mapping, 2009
- Central Auditory Dysfunction in Older Persons With Memory Impairment or Alzheimer DementiaJAMA Otolaryngology–Head & Neck Surgery, 2008
- MR‐based hippocampal volumetry in the diagnosis of Alzheimer's diseaseNeurology, 1992
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991